Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines.
Polysaccharide-encapsulated organisms are the leading cause of bacterial meningitis and pneumonia in children. The use of protein-polysaccharide conjugate vaccines in developed countries over the past two decades has markedly decreased the burden of disease and mortality from these organisms through...
Main Authors: | Pollard, A, Perrett, K, Beverley, P |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2009
|
Similar Items
-
Maintaining protection against invasive bacteria with protein - polysaccharide conjugate vaccines
by: Pollard, A, et al.
Published: (2009) -
Meningococcal polysaccharide-protein conjugate vaccines.
by: Snape, MD, et al.
Published: (2005) -
Long-term protection after immunization with protein-polysaccharide conjugate vaccines in infancy.
by: Blanchard-Rohner, G, et al.
Published: (2011) -
Meningococcal A, C, Y and W-135 polysaccharide-protein conjugate vaccines.
by: Pace, D, et al.
Published: (2007) -
Meningococcal polysaccharide-protein conjugate vaccines (vol 5, pg 21, 2005)
by: Snape, MD, et al.
Published: (2005)